New virus is capable of attacking 99% of HIV strains
According to the International Aids Society this is an exciting breakthrough. Human trials will begin in 2018 to see if it is possible to prevent or treat infections. According to Linda-Gail Bekker, the group's president, these antibodies seem to go beyond the natural and may have applications than anticipated.
How the antibody works
Researchers explain that in our body we have antibodies that fight to combat HIV. Unfortunately, this virus has a great ability to modify itself, making it difficult for the immune system to function.
However, some patients are able to develop broad, attacking neutralizing antibodies capable of killing extensions of HIV strains. The scientists' creation combines three broadly neutralizing types of antibodies as a way to treat HIV, or prevent infection. They are more powerful and more efficient than the ones we have in our body.
So far, the experiment was done with 24 monkeys and experts realized that they had an impressive degree of protection.
The National Agency of Sanitary Surveillance (Anvisa) approved the registration of a new medicine for the treatment of Hepatitis C. The approval was published in the Official Gazette (DOU) , according to Anvisa, Maviret (glecaprevir / pibrentasvir) will be marketed in the form of a coated tablet with a concentration of 100mg and 40mg.
Approximately a quarter of Americans are so afraid of a dentist that they avoid treatment. Unfortunately, you may be putting your health at risk if you do not visit the dentist. Research shows that oral health can have an impact on your overall health. Periodic examinations to monitor bacterial infections like periodontal disease can even improve your health.